| RS192013345 |
DHCR24
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmosterolosis, Desmosterolosis |
| RS192013394 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS192023037 |
XYLT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS192027050 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS192031352 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, LAMC3-related disorder |
| RS192041220 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Cardiomyopathy |
| RS192044702 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type IV |
| RS192045738 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 35, Spinocerebellar ataxia type 35 |
| RS192047082 |
COL9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing impairment, Stickler syndrome |
| RS192056427 |
MYLK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS192057022 |
MYL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 10 |
| RS192059823 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS192060920 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS192078749 |
COX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardioencephalomyopathy, fatal infantile |
| RS192080780 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
LEOPARD syndrome 1, Noonan syndrome 1 |
| RS192084195 |
PLCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
PLCE1-related disorder, Inborn genetic diseases |
| RS1920930432 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS1920931611 |
TCF20
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS1920933220 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS192093489 |
MBTPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1921012081 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1921041608 |
LAMP2
|
Health Risk |
Pathogenic |
— |
| RS1921053197 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1921088321 |
TCF20
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1921109201 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1921140611 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS1921146718 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS192117840 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Inborn genetic diseases |
| RS192119790 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS1921197915 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS192120666 |
DNAH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Ciliary dyskinesia, primary |
| RS192128801 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS192131551 |
PINK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive early-onset Parkinson disease 6, Uveal melanoma |
| RS192135533 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO5B-related disorder, Inborn genetic diseases |
| RS1921403332 |
DCX
|
Health Risk |
Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Subcortical laminar heterotopia |
| RS1921404698 |
DCX
|
Health Risk |
Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Lissencephaly type 1 due to doublecortin gene mutation |
| RS192143556 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS192152102 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Myopathy |
| RS192159089 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Idiopathic hypereosinophilic syndrome |
| RS1921622 |
IL1RL1
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS192163925 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, FLNC-related disorder |
| RS1921663802 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS192167542 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS192171304 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, PCCA-related disorder |
| RS192173278 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS192176115 |
GNAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 4, Achromatopsia 4 |
| RS192176652 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1921773433 |
IL2RB
|
Health Risk |
Pathogenic |
— |
| RS192179523 |
RIMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1921817445 |
PIGA
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Paroxysmal nocturnal hemoglobinuria 1 |
| RS1921817809 |
PIGA
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS192188850 |
CHMP2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7, CHMP2B-related disorder |
| RS192191038 |
PKLR
|
Health Risk |
Likely pathogenic |
— |
| RS1921924356 |
PIGA
|
Health Risk |
Likely pathogenic |
Paroxysmal nocturnal hemoglobinuria 1, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS192196274 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS192196713 |
WDPCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 15 |
| RS192197684 |
ITGB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1922018671 |
IL2RB
|
Health Risk |
Likely pathogenic |
— |
| RS192206443 |
PDSS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis, Malignant tumor of esophagus |
| RS1922072844 |
IL2RB
|
Health Risk |
Pathogenic |
Immunodeficiency 63 with lymphoproliferation and autoimmunity, Immunodeficiency 63 with lymphoproliferation and autoimmunity |
| RS192207329 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS1922162801 |
PIGA
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS192216625 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1922171377 |
TSR2;FGD1
|
Health Risk |
Pathogenic |
— |
| RS1922179572 |
PIGA
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS192221816 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
A2ML1-related disorder, A2ML1-related disorder |
| RS192225415 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, FRAS1-related disorder |
| RS192227753 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydrocephalus, nonsyndromic |
| RS1922317423 |
FGD1
|
Health Risk |
Likely pathogenic |
— |
| RS192232825 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS192232907 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1922347865 |
FGD1
|
Health Risk |
Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS192234924 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS192236678 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS192239366 |
RDX
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 24, RDX-related disorder |
| RS192242583 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 5, Cerebrooculofacioskeletal syndrome 1 |
| RS192242889 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
UNC80-related disorder, UNC80-related disorder |
| RS192248377 |
TNNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS1922506770 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS1922524280 |
PTCHD1
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1922605766 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1922607139 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1922607301 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS192260997 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Sialuria, GNE myopathy |
| RS192262279 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Rabin-Pappas syndrome |
| RS192264403 |
RFT1
|
Health Risk |
Conflicting classifications of pathogenicity |
RFT1-congenital disorder of glycosylation, RFT1-related disorder |
| RS192268080 |
CDAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, congenital dyserythropoietic |
| RS192272765 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS192275019 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1922801133 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 2 |
| RS192285113 |
OFD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Orofaciodigital syndrome I |
| RS1922859149 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS1922869724 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS1922871430 |
PTCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS1922885735 |
PTCHD1
|
Health Risk |
Pathogenic |
— |
| RS1922892999 |
PTCHD1
|
Health Risk |
Likely pathogenic |
Non-syndromic X-linked intellectual disability, Non-syndromic X-linked intellectual disability |
| RS192296154 |
IQCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Senior-Loken syndrome 5, Nephronophthisis |
| RS192302611 |
PSEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1U, Alzheimer disease 3 |
| RS192303222 |
ADSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1923115287 |
BMP15
|
Health Risk |
Likely pathogenic |
Ovarian dysgenesis 2, Ovarian dysgenesis 2 |